[CAS NO. 1383716-40-2]  PIK-III

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1383716-40-2]

Store
Catalog
SLK-S7683
Brand
Selleck
CAS
1383716-40-2

DESCRIPTION [1383716-40-2]

Overview

MDL-
Molecular Weight319.36
Molecular FormulaC17H17N7
SMILESNC1=NC=C(C2=NC(NC3=CC=NC=C3)=NC=C2)C(CC4CC4)=N1

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM3.1313 mL15.6563 mL31.3126 mL
5 mM0.6263 mL3.1313 mL6.2625 mL
10 mM0.3131 mL1.5656 mL3.1313 mL
50 mM0.0626 mL0.3131 mL0.6263 mL

Description

PIK-III (VPS34-IN2), which is a selective inhibitor of ​VPS34 enzymatic activity, inhibits and de novo lipidation of LC3 and leads to the stabilization of autophagy substrates. The IC50 values for VPS34 and PI(3)Kδ are 0.018 μM and 1.2 μM respectively.

Targets

Vps34 [1]
(Cell-free assay)
PI3Kδ [1]
(Cell-free assay)
0.018μM1.2μM

In vitro

VPS34 enzymatic function is essential for LC3 lipidation in mammalian cells and PIK-III is a robust inhibitor of autophagy and LC3 lipidation in mammalian cells. In H4 cells, PIK-III inhibits the formation of autolysosomes and increases the cytosolic signal of LC3 under basal conditions and when autophagy is induced with the mTOR inhibitor AZD8055. In a CCCP-induced mitophagy model, PIK-III inhibits the clearance of mitochondria.PIK-III treatment leads to an increase in the levels of LC3-I in H4 and PSN1 cells. In Panc10.05 cells, PIK-III increases the levels of LC3-II in parallel with LC3-I suggesting a cell type-specific response.